Ratnakar Securities Pvt. Ltd.

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1861.75-0.25 (-0.01 %)

PREV CLOSE ( ) 1862.00

OPEN PRICE ( ) 1755.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 316

TODAY'S LOW / HIGH ( )1755.00 1894.70

52 WK LOW / HIGH ( )1246.75 3375.45

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1987

Management Info

Bhupendra V Gandhi - Chairman Rajiv Gandhi - Managing Director

Registered Office

Address Meda Adraj , Kadi, , ,
Mehsana,
Gujarat-384441

Phone 079 â€“ 26445106

Email mail@hester.in

Website www.hester.in

Registrars Details

MUFG Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE

NEWS

10May Hester Biosciences informs about news
In compliance with Regulation 30 of the SEBI (Listing Obligations and Di..

09May Hester Biosciences informs about outco
Hester Biosciences has informed that with reference to the letter dated..

09May Hester Biosciences informs about outco
Hester Biosciences has informed that Board of Directors, in their Meetin..

02May Hester Biosciences informs about board
Hester Biosciences has informed that, as per Regulation 29 of the SEBI (..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	96.3499999999999	318.42
Gross Profit	114.83	417.6
Operating Profit	147.6	557.08
Net Sales	766.72	2864.66

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Vimta Labs (BSE) 1006.20 (3.26%)	M.Cap ( in Cr)2239.08
Supriya Lifescience (BSE) 699.90 (2.92%)	M.Cap ( in Cr)5632.99
Jenburkt Pharma (BSE) 1281.95 (1.22%)	M.Cap ( in Cr)565.76
Aayush Wellness (BSE) 160.20 (1.97%)	M.Cap ( in Cr)779.72
Parnax Lab (BSE) 107.45 (1.99%)	M.Cap ( in Cr)123.41

Shareholding Pattern

	PROMOTERS	53.73%
	NON-INSTITUTION	45.39%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal BSE H...	0.04
Bandhan BSE Healthc...	0.04

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

HESTER BIOSCIENCES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES